Doxycycline levels and adherence study
Part of Infections clinical trials.
This study looks at how the antibiotic doxycycline stays in your body and how well people stick to taking it. It may help find better ways to prevent infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a negative HIV test at screening.
- You have at least 1 cm of natural hair (no bleach, dye, perm, or relaxer) and can keep it that way during the study.
- If you can become pregnant, you must have a negative pregnancy test and use two effective birth control methods.
- You have a smartphone or laptop and can do video calls for directly observed dosing.
- You are in good general health and can swallow pills.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking a daily antibiotic (doxycycline) can prevent sexually transmitted infections in people at high risk. If you've had an STI recently and sometimes have sex without condoms, you might be able to join.
This study tests whether taking a short course of the antibiotic doxycycline after sex can prevent bacterial STIs (like chlamydia, gonorrhea, and syphilis) in women at higher risk. It lasts one year and uses a smartphone app to track your health.
This trial tests if taking doxycycline after sex can lower the risk of getting sexually transmitted infections (STIs) in men who have sex with men and are at higher risk.
This study looks at how a single 200 mg dose of doxycycline works in the body to prevent bacterial sexually transmitted infections (like chlamydia, gonorrhea, and syphilis) after a risky sexual encounter. It is for men who have sex with men and are already on PrEP or living with HIV.
This trial tests whether taking doxycycline can lower the chance of getting bacterial sexually transmitted infections like syphilis, gonorrhea, and chlamydia. It is aimed at men who have had these infections recently and expect to keep having multiple male partners.
This trial tests whether taking the antibiotic doxycycline can prevent sexually transmitted infections (STIs) like chlamydia, gonorrhea, and syphilis in people at higher risk. If you are a man or transgender woman who has sex with men, are living with HIV or on PrEP, and have had an STI in the past year, you may be able to join.
Hear when a new Sexually Transmitted Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.